Perception

Perception Neuroscience is a biotechnology company developing a new antidepressant drug called R-ketamine. Unlike existing antidepressants which can take weeks to work, R-ketamine belongs to a class of compounds that act rapidly, often within hours. R-ketamine is based on ketamine, an anesthetic drug that was found to quickly improve depression symptoms. 

Perception Neuroscience is testing R-ketamine as a potential rapid-acting antidepressant that can overcome the limitations of current depression treatments. The company is conducting clinical trials to evaluate the safety and efficacy of R-ketamine. If successful, this drug could provide much faster relief for people suffering from major depressive disorder and treatment-resistant depression. Perception aims to develop R-ketamine as a convenient antidepressant without the adverse effects and safety concerns of ketamine.